The Neurology Research Group

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Migraine1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Suspended1 trial
• Terminated1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Eli Lilly and Company1 trial
• Pfizer1 trial
• Techfields Inc1 trial

Running trials

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Terminated

  A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

  NCT04804033· Phase 2/3· Pfizer· Source